electroCore, Inc. Announces Study of gammaCore Sapphire™ for the Treatment of Post-COVID Syndrome
07 juil. 2022 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., July 07, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced Mayo Clinic is initiating an...
Odyssey Health, Inc. Completes Safety Evaluation of Cohort II for Concussion Drug
29 juin 2022 08h30 HE
|
Odyssey Health, Inc
Las Vegas, NV, June 29, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-saving medical products,...
Odyssey Health, Inc. Completes Safety Evaluation of Cohort I for Concussion Drug
01 juin 2022 09h00 HE
|
Odyssey Health, Inc
Irvine, CA, June 01, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-saving medical products,...
electroCore, Inc. Announces gammaCore™ Non-Invasive Vagus Nerve Stimulator Available Through National Spine and Pain Centers
24 mai 2022 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., May 24, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the gammaCore Sapphire™ non-invasive vagus...
electroCore to Participate at Upcoming Investor Conferences
18 mai 2022 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., May 18, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that electroCore’s Chief Executive Officer, Dan...
Study: Improvements in TBI Patients with Persistent Brain Fog
16 mai 2022 07h58 HE
|
Posit Science
SAN FRANCISCO, May 16, 2022 (GLOBE NEWSWIRE) -- A new study has shown that plasticity-based brain training can drive improvements in patients with persistent symptoms from Traumatic Brain Injury...
electroCore Announces Record First Quarter 2022 Financial Results
05 mai 2022 16h00 HE
|
electroCore, Inc.
First quarter 2022 net sales of $1.9 million, approximately 58% over first quarter 2021 and 27% sequentially Company to host a conference call and webcast today, May 5, 2022 at, 4:30 PM EDT ...
Odyssey Health, Inc. Announces Positive Results from Initial Phase I Clinical Trial Subjects for Concussion Drug
05 mai 2022 08h30 HE
|
Odyssey Group Intl Inc.
Irvine, CA, May 05, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-saving medical products,...
electroCore to Announce First Quarter 2022 Financial Results on May 5
28 avr. 2022 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., April 28, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that it will report financial results for the...
electroCore Completes Sale of New Jersey Tax Benefits
26 avr. 2022 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., April 26, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it has completed the sale of its...